(via Thenewswire.ca)
December 19, 2014 / TNW-ACCESSWIRE / Vancouver, British Columbia, Toronto, Ontario and New York, NY / Graphene 3D Lab Inc. (TSX-V: GGG, OTCQB: GPHBF) ("Graphene 3D") is pleased to announce that the Company intends to complete, subject to regulatory approval, a non-brokered private placement financing pursuant to which a total of 1,000,000 units (Units) will be available for subscription at a price of CDN$ 1.00 per unit for gross proceeds of CDN$ 1,000,000. Each Unit is comprised of one common share and one half warrant common share purchase. Each whole warrant entitles the holder to purchase a common share for CDN$ 1.25 for a period of two years. The company intends use the financing for further research and development and general working capital.
About Graphene 3D
Graphene 3D Lab is in the business of developing, manufacturing, and marketing proprietary graphene-based nanocomposite materials for various types of 3D printing, including fused filament fabrication. The Company is also involved in the design, manufacture, and marketing of 3D printers and related products for domestic and international customers.
The Graphene 3D Lab facility is located in Calverton, NY and is equipped with material processing and analytical equipment. The company has three US patent applications pending for its technology. For more information on Graphene 3D Lab, Inc., visit www.graphene3dlab.com.
For more information, please contact:
|
Commercial Inquiries:
Daniel Stolyarov
President & Chief Executive Officer
Telephone: (631) 405-5116
Email: daniel.stolyarov@graphene3dlab.com
|
Investor Inquiries:
Investor Relations
Telephone (631) 405-5114
Email: investors@graphene3dlab.com
|
|
Media Inquiries:
Marc Weinstein
Rubenstein Public Relations
Telephone: (212) 843-9240
Email: mweinstein@rubensteinpr.com
|
|
FORWARD LOOKING INFORMATION
This news release contains "forward-looking information" within the meaning of applicable securities laws. Forward-looking information in this news release includes statements about proceeds of the private placement and future closings.
A number of factors beyond the control of Graphene 3D Lab could cause the aforementioned future closings to be delayed or cancelled, including general market conditions, failure to locate subscribers willing to participate or failure to obtain the necessary regulatory approvals. The results or events predicted in these forward-looking statements may differ materially from actual results or events.
A more complete discussion of the risks and uncertainties facing the Company is disclosed in the Company's continuous disclosure filings with Canadian securities regulatory authorities at www.sedar.com. All forward-looking information herein is qualified in its entirety by this cautionary statement, and the Company disclaims any obligation to revise or update any such forward-looking information or to publicly announce the result of any revisions to any of the forward-looking information contained herein to reflect future results, events or developments, except as required by law.
THE FORWARD-LOOKING INFORMATION CONTAINED IN THIS PRESS RELEASE REPRESENTS THE EXPECTATIONS OF THE COMPANY AS OF THE DATE OF THIS PRESS RELEASE AND, ACCORDINGLY, IS SUBJECT TO CHANGE AFTER SUCH DATE. READERS SHOULD NOT PLACE UNDUE IMPORTANCE ON FORWARD-LOOKING INFORMATION AND SHOULD NOT RELY UPON THIS INFORMATION AS OF ANY OTHER DATE. WHILE THE COMPANY MAY ELECT TO, IT DOES NOT UNDERTAKE TO UPDATE THIS INFORMATION AT ANY PARTICULAR TIME EXCEPT AS REQUIRED IN ACCORDANCE WITH APPLICABLE LAWS.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Copyright (c) 2014 TheNewswire - All rights reserved.